The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

The Pharma Data

OCTOBER 27, 2020

On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.

RNA 52

RNA Drug Delivery Production In-Vitro 52

The Pharma Data

JANUARY 18, 2021

According to Health Canada, “the information currently available at the Controlled Substances Directorate, 2-bromo-LSD is NOT CONTROLLED under the Schedules to the Controlled Drugs and Substances Act.”. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. BetterLife Pharma Inc.

Containment 40

Containment Regulation Production Drug Delivery 40

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. BetterLife Pharma Inc. Source link.

Containment 52

Containment Drug Delivery Compliance Marketing 52

The Pharma Data

DECEMBER 14, 2020

While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. BetterLife Pharma Inc.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. The Company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. . +46 7686 650 11. 2 Proof of Concept.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 26, 2020

As drug molecules become more complex so do the options to deliver them. There are significant challenges in drug development in this space and we look forward to working closely with pharma and biotech partners to discover how we can add value to their programs, provide patient benefit and competitive product differentiation.”

Containment 52

Containment Medicine Bioavailability Clinical Trials 52

The Pharma Data

JANUARY 17, 2021

Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. Drug Formulations and Delivery. Commercialization of rapid COVID-19 PCR test. Diagnostics. “2020 was a very productive year for XPhyto. .

Production 40

Production Drug Delivery Development Drugs 40

The Pharma Data

NOVEMBER 4, 2020

is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and phyto-therapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and emerging plant-based therapeutics focused on European markets.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40

The Pharma Data

OCTOBER 27, 2020

DermSafe is listed by Health Canada under its approved products “ Disinfectants and hand sanitizers accepted under COVID-19 interim measure ” and has two Drug Identification Numbers (DIN) for personal use and personal commercial use. Statements have not been evaluated by Health Canada. Visit our website www.ovationscience.com.

Sales 52

Sales Production Drug Delivery Development 52

XTalks

MAY 30, 2023

The patch itself is made of biodegradable nanocellulose and contains no plastic additives. The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. Behfar, senior scientist at VTT, in the news release.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

The Pharma Data

JANUARY 27, 2021

Construction of commercial drug manufacturing facility in Germany. Psychedelic transdermal and sublingual drug formulation development. Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

JANUARY 15, 2021

Food and Drug Administration (FDA) approval of Darzalex Faspro ® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1] Janssen Biotech, Inc.

FDA Approval 52

FDA Approval Production Research Doctors 52

The Pharma Data

JANUARY 25, 2021

” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR). Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) isa drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Containment 52

Containment Drug Delivery Licensing Licensing 52

The Pharma Data

JANUARY 27, 2021

FDA Investigational New Drug (“IND”)-enabling pharmacology studies. About Eurofins Discovery: Eurofins Discovery, a business operating under the Eurofins BioPharma Services division, has supported drug discovery research for over 40 years. About BetterLife Pharma: BetterLife Pharma Inc. For more information, please visit: [link].

In-Vitro 52

In-Vitro Containment Drugs Production 52

The Pharma Data

APRIL 27, 2021

Recently the company submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration based on data from the Phase 3 GEMINI 1 and GEMINI 2 clinical studies. A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants.

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

XTalks

AUGUST 30, 2022

Due to consistent changes in pharmaceutical regulation, pandemic-related disturbances and the ongoing effects of digitization, visionary leaders could find themselves co-constructing their vision. Although these leadership styles are of very different natures, they also contain some commonalities. Transformational Leadership.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

Pharmaceutical Technology

FEBRUARY 3, 2023

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drug delivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.

Contamination 130

Contamination Manufacturing Containment Production 130